What is Allakos Inc's official website?

Allakos Inc's website is allakos.com

What is Allakos Inc's industry?

Allakos Inc's industry is Biotechnology Research

Who are Allakos Inc's top competitors?

Allakos Inc's top competitors are , , , , , ,

Allakos Inc company information, Employees & Contact Information

Explore related pages

Allakos Inc email format Allakos Inc management contacts

Related company profiles:

Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.

Employees: 41
Address: 975 Island Dr,
Phone: (650)597-5002
Email: in****@****kos.com
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: allakos.com
HQ: Redwood City, California
Competitors: Maze Therapeutics, Atara Biotherapeutics, Firefly Bio, Asher Biotherapeutics, Allogene Therapeutics, 3T Biosciences, Vaxcyte, Akero Therapeutics, Dren Bio, Inc., CARGO Therapeutics.

Allakos Inc Questions

News

Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts - Fierce Biotech

Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts Fierce Biotech

Biotech Deal Alert: Concentra Biosciences Acquires Allakos - Key Terms Revealed - Stock Titan

Biotech Deal Alert: Concentra Biosciences Acquires Allakos - Key Terms Revealed Stock Titan

Allakos Inc. Discontinues AK006 Development Following Phase 1 Trial Results, Plans Workforce Reduction - Nasdaq

Allakos Inc. Discontinues AK006 Development Following Phase 1 Trial Results, Plans Workforce Reduction Nasdaq

Allakos And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Allakos And 2 Other Promising Penny Stocks To Watch Yahoo Finance

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos Endpoints News

Bay Area biotech firm Allakos suddenly on brink of collapse after trial flops - SFGATE

Bay Area biotech firm Allakos suddenly on brink of collapse after trial flops SFGATE

Allakos Will Axe 75% of Workforce, Drop Hives Candidate - BioSpace

Allakos Will Axe 75% of Workforce, Drop Hives Candidate BioSpace

Allakos axes program, lays off 75% of staff and seeks strategic alternatives after phase 1 flop - Fierce Biotech

Allakos axes program, lays off 75% of staff and seeks strategic alternatives after phase 1 flop Fierce Biotech

Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8 - Wiley Online Library

Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8 Wiley Online Library

Allakos to lay off half of staff, scrap drug after study setback - BioPharma Dive

Allakos to lay off half of staff, scrap drug after study setback BioPharma Dive

Allakos completes merger with Concentra Biosciences - Investing.com

Allakos completes merger with Concentra Biosciences Investing.com

Why Is Allakos (ALLK) Stock Soaring 25% Today? - InvestorPlace

Why Is Allakos (ALLK) Stock Soaring 25% Today? InvestorPlace

Allakos cuts 75% of workforce after chronic hives trial failure - Pharmaceutical Technology

Allakos cuts 75% of workforce after chronic hives trial failure Pharmaceutical Technology

Allakos Appoints Baird Radford as Chief Financial Officer - citybiz

Allakos Appoints Baird Radford as Chief Financial Officer citybiz

Second Allakos drug programme hits dead end, triggering layoffs - FirstWord Pharma

Second Allakos drug programme hits dead end, triggering layoffs FirstWord Pharma

Allakos decimated as Phase I Trial of AK006 fails - The Pharma Letter

Allakos decimated as Phase I Trial of AK006 fails The Pharma Letter

Allakos cuts employee count by half after two Phase II failures - Pharmaceutical Technology

Allakos cuts employee count by half after two Phase II failures Pharmaceutical Technology

Allakos agrees to Concentra Biosciences acquisition - Investing.com

Allakos agrees to Concentra Biosciences acquisition Investing.com

Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku - Endpoints News

Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku Endpoints News

Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount - Fierce Biotech

Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount Fierce Biotech

Allakos Completes Merger with Concentra Biosciences - TipRanks

Allakos Completes Merger with Concentra Biosciences TipRanks

After flunking studies last year, Allakos' failed phase 3 EoDyssey sinks gastrointestinal program - Fierce Biotech

After flunking studies last year, Allakos' failed phase 3 EoDyssey sinks gastrointestinal program Fierce Biotech

Allakos faces delisting risk, given Nasdaq minimum bid notice - Investing.com

Allakos faces delisting risk, given Nasdaq minimum bid notice Investing.com

Allakos forced to regroup after skin diseases treatment fails – twice - FirstWord Pharma

Allakos forced to regroup after skin diseases treatment fails – twice FirstWord Pharma

Allakos shares plunge as company’s top drug falls short in studies - BioPharma Dive

Allakos shares plunge as company’s top drug falls short in studies BioPharma Dive

Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha

Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) Seeking Alpha

Allakos Announces AK002 Met All Prespecified Primary and - GlobeNewswire

Allakos Announces AK002 Met All Prespecified Primary and GlobeNewswire

Allakos Axes Half of Its Workforce, Drops Lead Inflammatory Candidate - BioSpace

Allakos Axes Half of Its Workforce, Drops Lead Inflammatory Candidate BioSpace

Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade - Stocktwits

Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade Stocktwits

Here's Why We're A Bit Worried About Allakos' (NASDAQ:ALLK) Cash Burn Situation - simplywall.st

Here's Why We're A Bit Worried About Allakos' (NASDAQ:ALLK) Cash Burn Situation simplywall.st

Allakos (ALLK) Stock Price, News & Analysis - MarketBeat

Allakos (ALLK) Stock Price, News & Analysis MarketBeat

Why Allakos Stock Plummeted 87.5% in the Last Month of 2021 - The Motley Fool

Why Allakos Stock Plummeted 87.5% in the Last Month of 2021 The Motley Fool

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation - Frontiers

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation Frontiers

ALLK Stock: Is It All Over for Allakos After the Trial Results? - Market Realist

ALLK Stock: Is It All Over for Allakos After the Trial Results? Market Realist

Shares of biotech company Allakos lost 90% of their value after its drug failed 2 clinical trials - The Business Journals

Shares of biotech company Allakos lost 90% of their value after its drug failed 2 clinical trials The Business Journals

Allergy, inflammation player Allakos reels in $100M series B - Fierce Biotech

Allergy, inflammation player Allakos reels in $100M series B Fierce Biotech

Why Is Allakos Soaring Today? - Market Realist

Why Is Allakos Soaring Today? Market Realist

Companies like Allakos Inc

Top Allakos Inc Employees

Kenneth White

Corporate Financial Planning And…

Danville, California, United States, United States

View

2
yahoo.com, boydcorp.com
Tony Championsmith

n/a

Seattle, Washington, United States, United States

View

2
earthlink.net, allakos.com
Baird Radford

n/a

San Jose, California, United States, United States

View

5
ebay.com, intusurg.com, heartflow.com, ebay.com, aimmune.com
Neil Graham

n/a

New York City Metropolitan Area, United States, United States

View

3
regeneron.com, hotmail.com, canadianorthodonticpartners.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Allakos Inc company information, Employees & Contact Information

Explore related pages

Company Details

Allakos Inc Questions

What is Allakos Inc's helpline number?

What is Allakos Inc's official website?

What is Allakos Inc's LinkedIn profile?

How many employees are working in Allakos Inc right now?

What is Allakos Inc's industry?

What are Allakos Inc's top competitors?

What is Allakos Inc's support email address?

What are Allakos Inc's categories?

News

Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts - Fierce Biotech

Biotech Deal Alert: Concentra Biosciences Acquires Allakos - Key Terms Revealed - Stock Titan

Allakos Inc. Discontinues AK006 Development Following Phase 1 Trial Results, Plans Workforce Reduction - Nasdaq

Allakos And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News

Bay Area biotech firm Allakos suddenly on brink of collapse after trial flops - SFGATE

Allakos Will Axe 75% of Workforce, Drop Hives Candidate - BioSpace

Allakos axes program, lays off 75% of staff and seeks strategic alternatives after phase 1 flop - Fierce Biotech

Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8 - Wiley Online Library

Allakos to lay off half of staff, scrap drug after study setback - BioPharma Dive

Allakos completes merger with Concentra Biosciences - Investing.com

Why Is Allakos (ALLK) Stock Soaring 25% Today? - InvestorPlace

Allakos cuts 75% of workforce after chronic hives trial failure - Pharmaceutical Technology

Allakos Appoints Baird Radford as Chief Financial Officer - citybiz

Second Allakos drug programme hits dead end, triggering layoffs - FirstWord Pharma

Allakos decimated as Phase I Trial of AK006 fails - The Pharma Letter

Allakos cuts employee count by half after two Phase II failures - Pharmaceutical Technology

Allakos agrees to Concentra Biosciences acquisition - Investing.com

Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku - Endpoints News

Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount - Fierce Biotech

Allakos Completes Merger with Concentra Biosciences - TipRanks

After flunking studies last year, Allakos' failed phase 3 EoDyssey sinks gastrointestinal program - Fierce Biotech

Allakos faces delisting risk, given Nasdaq minimum bid notice - Investing.com

Allakos forced to regroup after skin diseases treatment fails – twice - FirstWord Pharma

Allakos shares plunge as company’s top drug falls short in studies - BioPharma Dive

Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha

Allakos Announces AK002 Met All Prespecified Primary and - GlobeNewswire

Allakos Axes Half of Its Workforce, Drops Lead Inflammatory Candidate - BioSpace

Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade - Stocktwits

Here's Why We're A Bit Worried About Allakos' (NASDAQ:ALLK) Cash Burn Situation - simplywall.st

Allakos (ALLK) Stock Price, News & Analysis - MarketBeat

Why Allakos Stock Plummeted 87.5% in the Last Month of 2021 - The Motley Fool

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation - Frontiers

ALLK Stock: Is It All Over for Allakos After the Trial Results? - Market Realist

Shares of biotech company Allakos lost 90% of their value after its drug failed 2 clinical trials - The Business Journals

Allergy, inflammation player Allakos reels in $100M series B - Fierce Biotech

Why Is Allakos Soaring Today? - Market Realist

Companies like Allakos Inc

Akero Therapeutics

Maze Therapeutics

Firefly Bio

Asher Biotherapeutics

Cargo Therapeutics

Atara Biotherapeutics

Vaxcyte

Allogene Therapeutics

Dren Bio, Inc.

3T Biosciences

Top Allakos Inc Employees

Kenneth White

Corporate Financial Planning And…

Tony Championsmith

n/a

Baird Radford

n/a

Neil Graham

n/a

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data